Skip to main content
Clinical Trials/NCT06470958
NCT06470958
Recruiting
Not Applicable

Investigation of Functional Brain Features in Women with Migraine

Danish Headache Center1 site in 1 country40 target enrollmentApril 10, 2024
ConditionsMigraine

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Migraine
Sponsor
Danish Headache Center
Enrollment
40
Locations
1
Primary Endpoint
Brain excitability in migraine patients
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study aims to investigate whether the functional alterations in the brain of individuals with migraine appear before the peripheral vascular changes. This will be investigated using functional and structural neuroimaging in individuals with spontaneous menstually-related migraine.

Detailed Description

Spontaneous migraine attacks are unpredictable and therefore been logistically arduous to investigate in neuroimaging studies. Menstrually-related migraine provides an opportunity to study spontaneous attacks in a controlled imaging setup. The present project aims to investigate women with menstrually-related migraine using daily functional magnetic resonance imaging (MRI) scans 2-3 days before the onset of the menstrual bleeding and until (and including) the headache phase of migraine or up to five consecutive days. A control-group of women without migraine will also be recruited and undergo the same MRI scan protocol.

Registry
clinicaltrials.gov
Start Date
April 10, 2024
End Date
January 31, 2026
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Faisal Mohammad Amin

Principal Investigator

Danish Headache Center

Eligibility Criteria

Inclusion Criteria

  • For women with migraine
  • Episodic menstrually-related migraine without aura \> 12 months according to the International Classification of Headache Disorders 3rd Edition (ICHD-3) criteria
  • For women with migraine and healthy women
  • 18-40 years of age
  • Weight 50-100 kg
  • Regular menstruation

Exclusion Criteria

  • For women with migraine
  • Other primary headache disorders than migraine, except infrequent episodic tension-type headache according to the ICHD-3 criteria
  • Secondary headache disorders
  • Headache on the first scan day or 48 hours before the first scan
  • Absence of the menstruation for the past 12 months
  • Daily intake of medication of any kind except oral contraceptives
  • Ingestion of any type of medication later than 4 times the plasma half-life of the substance in question (on the day of the scan), except for oral contraceptives
  • Intake of coffee, tea or alcohol 12 hours prior to scan days
  • Fertile women not using safe contraception. Fertile women are defined as women without hysterectomy and \< 2 years postmenopausal women. Safe contraception includes the intrauterine device, oral contraceptive pills, surgical sterilization of the woman, depot progestogen or condoms
  • Change of hormonal contraceptives for the past 3 months

Outcomes

Primary Outcomes

Brain excitability in migraine patients

Time Frame: Up to 5 days in relation to menstruation

Changes in the migraine brain excitability in areas related to migraine during the menstrual period. This will be assessed functional magnetic resonance imaging.

Brain connectivity in migraine patients

Time Frame: Up to 5 days in relation to menstruation

Changes in the migraine brain connectivity in areas related to migraine during the menstrual period. This will be assessed functional magnetic resonance imaging.

Arterial circumference in migraine patients

Time Frame: Up to 5 days in relation to menstruation

Changes in arterial circumference during the menstrual period. This will assessed using Magnetic Resonance Angiography.

Arterial circumference after rescue medication in migraine patients

Time Frame: Up to 5 days in relation to menstruation

Changes in arterial circumference after rescue medication in migraine patients. This will assessed using Magnetic Resonance Angiography.

Brain excitability in healthy volunteers

Time Frame: Up to 5 days in relation to menstruation

Changes in brain excitability or connectivity in areas related to migraine during the menstrual period in healthy volunteers. This will be assessed using functional magnetic resonance imaging.

Brain connectivity in healthy volunteers

Time Frame: Up to 5 days in relation to menstruation

Changes in brain connectivity in areas related to migraine during the menstrual period in healthy volunteers. This will be assessed using functional magnetic resonance imaging.

Arterial circumference in healthy volunteers

Time Frame: Up to 5 days in relation to menstruation

Changes in arterial circumference during the menstrual period in healthy volunteers. This will assessed using Magnetic Resonance Angiography.

Secondary Outcomes

  • Migraine attacks during the menstrual period(Up to 7 days in relation to menstruation)
  • Association of the migraine attack features to brain excitability(Up to 5 days in relation to menstruation)
  • Association of the migraine attack features to functional connectivity(Up to 5 days in relation to menstruation)
  • Association of the migraine attack features to vasculature changes(Up to 5 days in relation to menstruation)

Study Sites (1)

Loading locations...

Similar Trials